MARYANN WESTBROOK: Open Payments
NPI 1558738930 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,198 in 85 payments from 20 companies in 2025. Trend: 2023 $2,560 · 2024 $2,790 · 2025 $2,198
Food & beverage: $1,975Education: $223
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $482 |
| GENZYME CORPORATION | 15 | $366 |
| AstraZeneca Pharmaceuticals LP | 11 | $263 |
| Novartis Pharmaceuticals Corporation | 7 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $130 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Genentech USA, Inc. | 4 | $76 |
| Grifols USA, LLC | 3 | $75 |
| Optinose US, Inc. | 3 | $70 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, Xhance, Rhapsido, Xolair, Xembify, RUCONEST.
Industry payments across FL — which companies pay providers there.
